Stuart R. Lessin, M.D

Dermatologist - Bryn Mawr Skin & Cancer

Dr Lessin is also a fellow of:

American Academy of Dermatology (Fellow)
Philadelphia College of Physicians (Fellow)
Society for Melanoma Research (Founding Member)

Honors and Awards:

            2005     America’s Top Doctors for Cancer (1st -5th editions, 2005-2010)
            2004     Best Doctors in America (2005-2010)
            2003     America’s Top Doctors (3rd – 9th editions, 2003-2010)
            2002     Dermatology Program Development Award, Dermatology Foundation
            1999     Mid-Career Development Award, National Institutes of Health
            1991     FIRST Award, National Institutes of Health
            1991     Career Development Award, Department of Veterans Affairs
            1990     Career Development Award, Dermatology Foundation
            1986     Physician Scientist Award, National Institutes of Health

Dr. Lessin was born and raised in the Philadelphia area and is a long time resident of Haverford. He graduated Penn State University and received his M.D from Temple University School of Medicine. He completed his residency training in dermatology at the Hospital of the University of Pennsylvania where he first worked with Dr. Cirillo. He received fellowship training in molecular biology at the Wistar Institute before joining the faculty of the Department of Dermatology of the University of Pennsylvania School of Medicine and served as a Co-Director of the Cutaneous Lymphoma Program and Pigmented Lesion Group. At Fox Chase Cancer Center he was Director of Dermatology and the Melanoma Family Risk Assessment Program.

Dr. Lessin has received national awards for his skin cancer research, authored over 100 medical and scientific publications and is internationally recognized as a leader in skin cancer care. He serves on the Boards of the Dermatology Foundation and the Cutaneous Lymphoma Foundation. He has been listed in America’s Top Doctors, America’s Best Doctors, America’s Best Doctors for Cancer and Top Doctors in Philadelphia since 2004. He now brings his expertise to the Bryn Mawr Skin and Cancer Institute.